156 related articles for article (PubMed ID: 30595381)
1. Overexpression of the steroidogenic acute regulatory protein in breast cancer: Regulation by histone deacetylase inhibition.
Manna PR; Ahmed AU; Vartak D; Molehin D; Pruitt K
Biochem Biophys Res Commun; 2019 Feb; 509(2):476-482. PubMed ID: 30595381
[TBL] [Abstract][Full Text] [Related]
2. Expression and Function of StAR in Cancerous and Non-Cancerous Human and Mouse Breast Tissues: New Insights into Diagnosis and Treatment of Hormone-Sensitive Breast Cancer.
Manna PR; Ramachandran S; Pradeepkiran JA; Molehin D; Castro-Piedras I; Pruitt K; Ganapathy V; Reddy PH
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614200
[TBL] [Abstract][Full Text] [Related]
3. Hormonal and Genetic Regulatory Events in Breast Cancer and Its Therapeutics: Importance of the Steroidogenic Acute Regulatory Protein.
Manna PR; Ahmed AU; Molehin D; Narasimhan M; Pruitt K; Reddy PH
Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740335
[TBL] [Abstract][Full Text] [Related]
4. Expression of calcium pumps is differentially regulated by histone deacetylase inhibitors and estrogen receptor alpha in breast cancer cells.
Varga K; Hollósi A; Pászty K; Hegedűs L; Szakács G; Tímár J; Papp B; Enyedi Á; Padányi R
BMC Cancer; 2018 Oct; 18(1):1029. PubMed ID: 30352569
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.
Lapierre M; Linares A; Dalvai M; Duraffourd C; Bonnet S; Boulahtouf A; Rodriguez C; Jalaguier S; Assou S; Orsetti B; Balaguer P; Maudelonde T; Blache P; Bystricky K; Boulle N; Cavaillès V
Oncotarget; 2016 Apr; 7(15):19693-708. PubMed ID: 26930713
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Dysregulation and Its Correlation with the Steroidogenic Machinery Impacting Breast Pathogenesis: Data Mining and Molecular Insights into Therapeutics.
Manna PR; Yang S; Reddy PH
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003678
[TBL] [Abstract][Full Text] [Related]
7. Genomic Profiling of the Steroidogenic Acute Regulatory Protein in Breast Cancer: In Silico Assessments and a Mechanistic Perspective.
Manna PR; Ahmed AU; Yang S; Narasimhan M; Cohen-Tannoudji J; Slominski AT; Pruitt K
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31060224
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronate synthase-2 overexpression alters estrogen dependence and induces histone deacetylase inhibitor-like effects on ER-driven genes in MCF7 breast tumor cells.
Vanneste M; Hanoux V; Bouakka M; Bonnamy PJ
Mol Cell Endocrinol; 2017 Mar; 444():48-58. PubMed ID: 28137613
[TBL] [Abstract][Full Text] [Related]
9. Aromatase Acetylation Patterns and Altered Activity in Response to Sirtuin Inhibition.
Molehin D; Castro-Piedras I; Sharma M; Sennoune SR; Arena D; Manna PR; Pruitt K
Mol Cancer Res; 2018 Oct; 16(10):1530-1542. PubMed ID: 29921733
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibition and estrogen signalling in human breast cancer cells.
Margueron R; Duong V; Castet A; Cavaillès V
Biochem Pharmacol; 2004 Sep; 68(6):1239-46. PubMed ID: 15313422
[TBL] [Abstract][Full Text] [Related]
11. Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression.
Raha P; Thomas S; Thurn KT; Park J; Munster PN
Breast Cancer Res; 2015 Feb; 17(1):26. PubMed ID: 25848915
[TBL] [Abstract][Full Text] [Related]
12. An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression.
Simpson NE; Tryndyak VP; Beland FA; Pogribny IP
Breast Cancer Res Treat; 2012 Jun; 133(3):959-68. PubMed ID: 22101407
[TBL] [Abstract][Full Text] [Related]
13. A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine.
Keen JC; Yan L; Mack KM; Pettit C; Smith D; Sharma D; Davidson NE
Breast Cancer Res Treat; 2003 Oct; 81(3):177-86. PubMed ID: 14620913
[TBL] [Abstract][Full Text] [Related]
14. Induction of 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13.
Gingras S; Moriggl R; Groner B; Simard J
Mol Endocrinol; 1999 Jan; 13(1):66-81. PubMed ID: 9892013
[TBL] [Abstract][Full Text] [Related]
15. Effects of apicidin, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
Park H; Im JY; Kim J; Choi WS; Kim HS
Int J Mol Med; 2008 Mar; 21(3):325-33. PubMed ID: 18288380
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin F2alpha suppresses rat steroidogenic acute regulatory protein expression via induction of Yin Yang 1 protein and recruitment of histone deacetylase 1 protein.
Liu Q; Merkler KA; Zhang X; McLean MP
Endocrinology; 2007 Nov; 148(11):5209-19. PubMed ID: 17702849
[TBL] [Abstract][Full Text] [Related]
17. Troglitazone inhibits histone deacetylase activity in breast cancer cells.
Davies GF; Ross AR; Arnason TG; Juurlink BH; Harkness TA
Cancer Lett; 2010 Feb; 288(2):236-50. PubMed ID: 19699029
[TBL] [Abstract][Full Text] [Related]
18. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells.
Yang X; Phillips DL; Ferguson AT; Nelson WG; Herman JG; Davidson NE
Cancer Res; 2001 Oct; 61(19):7025-9. PubMed ID: 11585728
[TBL] [Abstract][Full Text] [Related]
19. The Histone Acetylation Modifications of Breast Cancer and their Therapeutic Implications.
Guo P; Chen W; Li H; Li M; Li L
Pathol Oncol Res; 2018 Oct; 24(4):807-813. PubMed ID: 29948617
[TBL] [Abstract][Full Text] [Related]
20. Differential profiles of HDAC1 substrates and associated proteins in breast cancer cells revealed by trapping.
Zhang Y; Nalawansha DA; Herath KE; Andrade R; Pflum MKH
Mol Omics; 2021 Aug; 17(4):544-553. PubMed ID: 33885658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
